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The rise in infections caused by antimicrobial-resistant organisms continues to plague us. 
While resistance genes have been present for millions of years before the advent of modern 
antibiotics, frequent antibiotic exposure accelerates the emergence of resistance in almost all 
organisms that cause clinical infections. However, as most of the intuitive targets for 
antimicrobial agents have been exhausted and as antimicrobial development is not as 
lucrative as pharmaceutical manufacturers would desire, we are limited in our current 
antimicrobial treatment options now and in the foreseeable future. Thus, the most realistic, 
immediate approach is to improve our knowledge and use of existing antimicrobial agents.
Although implementation of antimicrobial stewardship programs across health care facilities 
is neither incentivized nor nationally mandated in the United States, there are on-going 
discussions about moving in this direction. Currently, the Centers for Disease Control and 
Prevention are supporting large studies to move the science of antimicrobial stewardship 
forward. They are also developing templates to highlight methods to start and expand 
stewardship programs in health care institutions with a focus on intervention strategies, 
measurement approaches, and education about resistance and optimal antibiotic use.
In the meantime, as we await policy changes, this issue of Infectious Disease Clinics of 
North America brings together leaders in the field to fill important gaps in knowledge in the 
world of antimicrobial stewardship, including improving antimicrobial knowledge of 
prescribers, changing prescriber behavior, utilizing sophisticated research methods and 
antimicrobial measurement approaches, incorporating novel diagnostic techniques into 
stewardship activities, and using advanced informatics to enhance stewardship programs. 
They venture into some nonhospital settings to discuss the role of antimicrobial stewardship, 
including long-term care facilities, community hospitals, neonatal intensive care units, and 
oncology and transplant wards. They also discuss innovative methods of improving 
antimicrobial prescribing practices, such as ward rounds, tackling antibiotic allergies, 
improving antimicrobial use during transitions of care and at the end of life, transferring 
some of the work of stewardship onto individual providers, and allocating stewardship 
resources when resources are limited.
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